Arrow International arterial catheter kits recalled for potentially compromised injectable medications
Arrow International catheter kits recalled for drug quality issues
Arrow International included lidocaine, bupivacaine, and saline solutions from a supplier with documented quality problems in multiple arterial catheter kits and sets. The supplier's medications showed signs of ineffectiveness, and if sterility was compromised, the kits could cause serious injury when used.
- Check if your facility has any of the affected Arrow International catheter kits listed in this recall.
- Stop using affected lots immediately and quarantine them.
- Contact your supplier or Arrow International for instructions on replacement or disposal.
- Review patient records if any affected kits were used and consult your medical team.
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2391-2026More Arrow recalls
- FDA-Device2026-06-24Arrow International hemodialysis kits recalled for contaminated anesthetic and saline solutions
- FDA-Device2026-06-24Arrow International PI CVC kits recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC kits and stylets recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC and JACC catheter kits recalled for contaminated anesthetic and saline components
- FDA-Device2026-06-24Arrow International Pacing PSI Kits recalled for potential drug ineffectiveness and sterility compromise
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief